抗癌治疗引起的儿童药物不良反应以及预防和控制措施
Hui Yan1,2, Penggao Wang2, Fang Yang2
1Henan Provincial Clinical Research Center for Pediatric Diseases, Henan Key Laboratory of Pediatric Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Henan Children's Hospital, Zhengzhou Children's Hospital, Zhengzhou, China.
儿童癌症患者由于器官功能不成熟和身体尺寸较小而经历了更多的化学疗法药物不良反应 (ADR). 本综述总结了儿童癌症治疗的系统性副作用和应对策略.
科学领域:
- 儿科瘤学 儿科瘤学
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
背景情况:
- 抗瘤药物开发使儿科瘤学取得了先进的进展,但儿童面临着独特的挑战.
- 儿童肝脏和脏功能不成熟会增加对药物不良反应 (ADR) 的敏感性.
- 在儿科患者中,体型较小和体表面积较大可能导致药物积累和毒性.
研究的目的:
- 系统地审查使用抗瘤药物治疗的儿童癌症患者的全身不良药反应 (ADR).
- 总结目前用于治疗儿童和青少年化疗相关副作用的策略.
- 为管理儿科癌症患者的临床医生和研究人员提供全面的资源.
主要方法:
- 在儿科瘤学中,与抗瘤药物相关的全身不良药反应 (ADR) 的文献综述.
- 副作用的分类包括神经毒性,血液,心脏,呼吸道,胃肠道和泌尿系统的毒性.
- 识别和总结已识别的ADR的管理策略.
主要成果:
- 化疗相关的不良反应显著影响儿科患者的癌症缓解.
- 常见的副作用包括神经毒性,血液毒性,心脏毒性以及对呼吸道,胃肠道和泌尿系统的影响.
- 皮肤反应,过敏反应和其他系统性毒性也被记录在案.
结论:
- 了解ADR的范围对于优化儿科癌症治疗至关重要.
- 有效的ADR管理策略对于改善治疗结果和生活质量至关重要.
- 本综述为进一步的研究和儿科瘤学临床实践提供了基础.
更多相关视频
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
04:48Chemotherapy-induced Vascular Toxicity - Real-time In vivo Imaging of Vessel Impairment
Published on: January 7, 2015
相关概念视频
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Factors Affecting Drug Response: Overview
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...
Treatment Resistant Cancers
